S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
Here's Bill Bonner's "4th and Final Prediction" (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Wall Street slips as weak earnings hit tech, travel stocks
Here's Bill Bonner's "4th and Final Prediction" (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
Here's Bill Bonner's "4th and Final Prediction" (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Wall Street slips as weak earnings hit tech, travel stocks
Here's Bill Bonner's "4th and Final Prediction" (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
Here's Bill Bonner's "4th and Final Prediction" (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Wall Street slips as weak earnings hit tech, travel stocks
Here's Bill Bonner's "4th and Final Prediction" (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
Here's Bill Bonner's "4th and Final Prediction" (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Wall Street slips as weak earnings hit tech, travel stocks
Here's Bill Bonner's "4th and Final Prediction" (Ad)
NASDAQ:PAHC

Phibro Animal Health - PAHC Stock Forecast, Price & News

$18.97
-0.17 (-0.89%)
(As of 08/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$18.84
$19.42
50-Day Range
$17.89
$20.30
52-Week Range
$17.28
$26.55
Volume
63,901 shs
Average Volume
90,976 shs
Market Capitalization
$768.36 million
P/E Ratio
13.08
Dividend Yield
2.51%
Price Target
$22.50

Phibro Animal Health MarketRank™ Forecast

Analyst Rating
Hold
1.50 Rating Score
Upside/​Downside
18.6% Upside
$22.50 Price Target
Short Interest
Healthy
4.75% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-5.07
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
5.88%
From $1.36 to $1.44 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.01 out of 5 stars

Medical Sector

659th out of 1,098 stocks

Pharmaceutical Preparations Industry

325th out of 536 stocks

PAHC stock logo

About Phibro Animal Health (NASDAQ:PAHC) Stock

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.

Phibro Animal Health Stock Up 2.4 %

PAHC Stock opened at $19.14 on Tuesday. The company has a current ratio of 2.92, a quick ratio of 1.59 and a debt-to-equity ratio of 1.50. Phibro Animal Health has a twelve month low of $17.28 and a twelve month high of $26.55. The company's 50 day moving average is $19.20 and its two-hundred day moving average is $19.48. The stock has a market cap of $775.25 million, a P/E ratio of 13.20 and a beta of 0.51.

Phibro Animal Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 28th. Stockholders of record on Wednesday, September 7th will be given a dividend of $0.12 per share. The ex-dividend date is Tuesday, September 6th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.51%. Phibro Animal Health's dividend payout ratio (DPR) is presently 33.10%.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on PAHC. TheStreet upgraded shares of Phibro Animal Health from a "c+" rating to a "b-" rating in a research note on Friday, July 29th. StockNews.com cut shares of Phibro Animal Health from a "strong-buy" rating to a "buy" rating in a research report on Thursday, May 5th. Finally, Barclays lowered shares of Phibro Animal Health from an "equal weight" rating to an "underweight" rating and set a $22.00 price objective for the company. in a report on Monday, July 25th.

Receive PAHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Phibro Animal Health and its competitors with MarketBeat's FREE daily newsletter.

PAHC Stock News Headlines

Is Phibro (PAHC) a Smart Investment Choice?
See More Headlines
Receive PAHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Phibro Animal Health and its competitors with MarketBeat's FREE daily newsletter.

PAHC Company Calendar

Last Earnings
11/02/2021
Ex-Dividend for 6/22 Dividend
5/31/2022
Dividend Payable
6/22/2022
Today
8/09/2022
Next Earnings (Confirmed)
8/24/2022
Ex-Dividend for 9/28 Dividend
9/06/2022
Dividend Payable
9/28/2022
Fiscal Year End
6/30/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PAHC
Employees
1,725
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$22.50
High Stock Price Forecast
$23.00
Low Stock Price Forecast
$22.00
Forecasted Upside/Downside
+18.6%
Consensus Rating
Hold
Rating Score (0-4)
1.50
Research Coverage
2 Analysts

Profitability

Net Income
$54.38 million
Pretax Margin
8.39%

Debt

Sales & Book Value

Annual Sales
$833.40 million
Cash Flow
$2.08 per share
Book Value
$5.89 per share

Miscellaneous

Free Float
20,228,000
Market Cap
$768.36 million
Optionable
Optionable
Beta
0.51

Key Executives

  • Mr. Jack Clifford Bendheim (Age 75)
    Chairman, Pres & CEO
    Comp: $3.69M
  • Mr. Damian Finio (Age 52)
    Chief Financial Officer
    Comp: $675.91k
  • Mr. Larry L. Miller (Age 58)
    Chief Operating Officer
    Comp: $1.04M
  • Mr. Thomas G. Dagger (Age 64)
    Sr. VP, Gen. Counsel & Corp. Sec.
    Comp: $717.1k
  • Mr. Daniel M. Bendheim (Age 50)
    Exec. VP of Corp. Strategy & Director
    Comp: $735.63k
  • Ms. Lisa A. Escudero (Age 60)
    Sr. VP of HR
  • Mr. Jonathan Bendheim (Age 46)
    Pres of MACIE Region, GM of Israel Operations & Director
  • Mr. Ramon Fuenmayor
    Pres South America Region
  • Mr. Rob Aukerman (Age 64)
    Pres of North America Region
  • Mr. Jean Christophe Filippi
    Pres of Asia Pacific Region













PAHC Stock - Frequently Asked Questions

Should I buy or sell Phibro Animal Health stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Phibro Animal Health in the last year. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" PAHC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PAHC, but not buy additional shares or sell existing shares.
View PAHC analyst ratings
or view top-rated stocks.

What is Phibro Animal Health's stock price forecast for 2022?

2 Wall Street research analysts have issued 1-year target prices for Phibro Animal Health's stock. Their PAHC share price forecasts range from $22.00 to $23.00. On average, they anticipate the company's share price to reach $22.50 in the next twelve months. This suggests a possible upside of 18.6% from the stock's current price.
View analysts price targets for PAHC
or view top-rated stocks among Wall Street analysts.

How has Phibro Animal Health's stock performed in 2022?

Phibro Animal Health's stock was trading at $20.42 at the beginning of the year. Since then, PAHC stock has decreased by 7.1% and is now trading at $18.97.
View the best growth stocks for 2022 here
.

When is Phibro Animal Health's next earnings date?

Phibro Animal Health is scheduled to release its next quarterly earnings announcement on Wednesday, August 24th 2022.
View our PAHC earnings forecast
.

How can I listen to Phibro Animal Health's earnings call?

Phibro Animal Health will be holding an earnings conference call on Thursday, August 25th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Phibro Animal Health's earnings last quarter?

Phibro Animal Health Co. (NASDAQ:PAHC) announced its earnings results on Tuesday, November, 2nd. The company reported $0.25 earnings per share for the quarter, missing the consensus estimate of $0.29 by $0.04. The firm had revenue of $214.70 million for the quarter. Phibro Animal Health had a trailing twelve-month return on equity of 21.06% and a net margin of 6.48%. During the same period in the previous year, the company earned $0.27 earnings per share.

How often does Phibro Animal Health pay dividends? What is the dividend yield for Phibro Animal Health?

Phibro Animal Health announced a quarterly dividend on Monday, July 25th. Stockholders of record on Wednesday, September 7th will be given a dividend of $0.12 per share on Wednesday, September 28th. This represents a $0.48 dividend on an annualized basis and a yield of 2.53%. The ex-dividend date of this dividend is Tuesday, September 6th.
Read our dividend analysis for PAHC
.

Is Phibro Animal Health a good dividend stock?

Phibro Animal Health (NASDAQ:PAHC) pays an annual dividend of $0.48 per share and currently has a dividend yield of 2.51%. The dividend payout ratio is 33.10%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, PAHC will have a dividend payout ratio of 33.33% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for PAHC.

What guidance has Phibro Animal Health issued on next quarter's earnings?

Phibro Animal Health issued an update on its FY 2022 earnings guidance on Monday, May, 16th. The company provided earnings per share (EPS) guidance of $1.30-$1.39 for the period, compared to the consensus estimate of $1.36. The company issued revenue guidance of $930.00 million-$950.00 million, compared to the consensus revenue estimate of $907.54 million.

What is Jack Bendheim's approval rating as Phibro Animal Health's CEO?

4 employees have rated Phibro Animal Health Chief Executive Officer Jack Bendheim on Glassdoor.com. Jack Bendheim has an approval rating of 100% among the company's employees. This puts Jack Bendheim in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Phibro Animal Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Phibro Animal Health investors own include Zynga (ZNGA), Trevena (TRVN), Endo International (ENDP), Sonoma Pharmaceuticals (SNOA), Zynerba Pharmaceuticals (ZYNE), Intercept Pharmaceuticals (ICPT), VIVUS (VVUS), Zoetis (ZTS), Banco Bradesco (BBD) and Booking (BKNG).

What is Phibro Animal Health's stock symbol?

Phibro Animal Health trades on the NASDAQ under the ticker symbol "PAHC."

Who are Phibro Animal Health's major shareholders?

Phibro Animal Health's stock is owned by a variety of institutional and retail investors. Top institutional investors include Pzena Investment Management LLC (4.78%), Victory Capital Management Inc. (1.11%), Smith Graham & Co. Investment Advisors LP (0.80%), Chartwell Investment Partners LLC (0.52%), Russell Investments Group Ltd. (0.44%) and Confluence Investment Management LLC (0.21%). Insiders that own company stock include E Thomas Corcoran and Larry Lee Miller.
View institutional ownership trends
.

How do I buy shares of Phibro Animal Health?

Shares of PAHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Phibro Animal Health's stock price today?

One share of PAHC stock can currently be purchased for approximately $18.97.

How much money does Phibro Animal Health make?

Phibro Animal Health (NASDAQ:PAHC) has a market capitalization of $768.36 million and generates $833.40 million in revenue each year. The company earns $54.38 million in net income (profit) each year or $1.45 on an earnings per share basis.

How many employees does Phibro Animal Health have?

Phibro Animal Health employs 1,725 workers across the globe.

How can I contact Phibro Animal Health?

Phibro Animal Health's mailing address is GLENPOINTE CENTRE EAST 3RD FLOOR 300 FRANK W. BURR BLVD. SUITE 21, TEANECK NJ, 07666. The official website for the company is www.pahc.com. The company can be reached via phone at (201) 329-7300, via email at investor.relations@pahc.com, or via fax at 201-329-7399.

This page (NASDAQ:PAHC) was last updated on 8/10/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.